Page last updated: 2024-10-18

gamma-butyrobetaine and Myocardial Ischemia

gamma-butyrobetaine has been researched along with Myocardial Ischemia in 1 studies

4-(trimethylammonio)butanoate : An amino-acid betaine gamma-aminobutyric acid zwitterion in which all of the hydrogens attached to the nitrogen are replaced by methyl groups.

Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sjakste, N1
Kleschyov, AL1
Boucher, JL1
Baumane, L1
Dzintare, M1
Meirena, D1
Sjakste, J1
Sydow, K1
Münzel, T1
Kalvinsh, I1

Other Studies

1 other study available for gamma-butyrobetaine and Myocardial Ischemia

ArticleYear
Endothelium- and nitric oxide-dependent vasorelaxing activities of gamma-butyrobetaine esters: possible link to the antiischemic activities of mildronate.
    European journal of pharmacology, 2004, Jul-08, Volume: 495, Issue:1

    Topics: Animals; Aorta, Thoracic; Betaine; Carnitine; Ditiocarb; Drug Combinations; Drug Evaluation, Preclin

2004